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Abstract 
Background: Impaired spatial navigation is an early sign of Alzheimer disease (AD), but this 
can be difficult to assess in clinical practice. We examined how the performance on the Floor 
Maze Test (FMT), which combines navigation with walking, differed between patients with 
subjective cognitive impairment (SCI), mild cognitive impairment (MCI), and mild AD. We 
also explored if there was a significant relationship between the FMT and the cognitive tests 
or sociodemographic factors. 
Methods: The study included 128 patients from a memory clinic classified as having SCI 
(n = 19), MCI (n = 20), and mild AD (n = 89). Spatial navigation was assessed by having the 
patients walk through the FMT, a two-dimensional maze. Both timed measures and number of 
errors were recorded. Cognitive function was assessed by the Word List Memory test, the 
Clock Drawing Test, the Trail Making Tests (TMT) A and B, and the Mini Mental Status 
Examination (MMSE). 
Results: The patients with MCI were slower than those with SCI, while the patients with mild 
AD more frequently completed the FMT with errors or gave up than the patients with MCI. 
Performance on the FMT was significantly associated with executive function (measured by 
TMT‒B). 
Conclusions: The performances on the FMT worsened with increasing severity of cognitive 
impairment, and the FMT was primarily associated with executive function. The explained 
variance was relatively low, which may indicate that the standard cognitive test battery does 
not capture impairments of spatial navigation. 
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Introduction 
Independent mobility in society requires not only sufficient motor function, but also the 
ability to navigate in both familiar and unfamiliar surroundings. Spatial navigation involves 
both route-planning and way-finding, and can be defined as the ability to determine and 
maintain a route from one place to another (Gallistel, 1990). Failure in spatial navigation may 
therefore lead to topographical disorientation and getting lost. Navigational skills decline with 
age (Cushman et al., 2008), and this decline is even more pronounced in individuals with 
Alzheimer disease (AD), where spatial disorientation is considered one of the earliest signs of 
the disease (Pai and Jacobs, 2004). Studies have found that approximately 50% of 
community-dwelling people with AD experience navigational impairment (deIpolyi et al., 
2007; Pai & Jacobs, 2004). This is likely because spatial navigation impairment is related to 
atrophy of the hippocampus and parahippocampal gyrus (deIpolyi et al., 2007; O'Keefe and 
Nadel, 1978), where the first neural losses are observed in patients with AD (Braak and Braak, 
1991).  Loss of confidence in navigational skills is likely to hamper activities of daily living 
(ADL). This was shown in a study where older drivers with self-perceived navigational 
impairments reported that they avoided unfamiliar routes and places and drove less than those 
who experienced no navigational problems (Burns, 1999).  Thus, navigational ability is 
therefore an important issue to address with regard to impact on daily activities, as well as in 
the light of early identification of AD.  
 
Descriptions of a continuum between healthy ageing and AD involve at-risk states referred to 
as subjective cognitive impairment (SCI) and mild cognitive impairment (MCI) (Reisberg et 
al., 2010).  MCI is characterized by a measurable decline in cognition, but still largely 
preserved functional abilities (Winblad et al., 2004), although some decrements in complex 
ADL are reported (Hesseberg et al., 2013). While MCI has a relatively well-established 
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position in the continuum between healthy aging and AD, SCI is considered a more 
heterogeneous condition, where there is no objective evidence of cognitive or functional 
impairments despite personal concern (Jessen et al., 2010). The risk of cognitive decline and 
progression to MCI and AD is higher for individuals with SCI than for healthy controls 
(Reisberg et al., 2010), but the estimated time for progression may be as long as 15 years 
(Reisberg et al., 2008). It is important to acknowledge that a substantial portion of people 
with SCI, as well as about half of them with MCI, remain cognitively stable and even cease to 
worry about their cognitive function. However, studies suggest that changes in spatial abilities 
occur before patients fill the criteria for AD.  In a longitudinal study, visuo-spatial abilities 
began to decline 3 years prior to a clinical diagnosis of AD (Johnson et al., 2009).  In cross-
sectional studies navigational impairments have also been reported in patients with MCI 
(Benke et al., 2013; deIpolyi et al., 2007; Hort et al., 2007), while patients with SCI have 
shown no impairment of their navigational skills relative to healthy controls (Hort et al., 2007; 
Kalova et al., 2005). However, literature on spatial navigational abilities in the continuum 
between healthy and AD is still scarce, and a reason might be that research is hampered by the 
lack of established consensus on how to conduct assessments of spatial navigation with real-
life applicability.  
 
Real-life spatial navigation is continuously and dynamically conducted in complex 
surroundings, and assessments that are ecologically valid are therefore difficult to perform in 
both the clinical and research settings. Studies aimed to reflect real-life  complexity of spatial 
navigation have assessed the ability to navigate in hospital settings (Benke et al., 2013; 
deIpolyi et al., 2007) or in advanced virtual reality (VR) settings (Cushman et al.2008). In 
clinical practice however, it is more common to use pencil-and-paper tests, probably because 
tests using real-life environments consume time and space, and VR equipment is seldom 
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available. The pencil-and-paper tests typically target visuo-construction and figure copying 
skills, which do represent one aspect of spatial abilities; however, the relationship between 
these tests and real-life navigation is not clear (Moffat, 2009). Both the traditional VR-tests 
and the pencil-and-paper tests lack the multisensory processes related to actual real-life 
navigation, where we hear, see, and move our bodies in relation to our surroundings. In one 
study of walking on a treadmill with and without support, the increased postural demands of 
walking without support was found to influence the performance on a VR-based spatial 
navigation task in cognitively healthy persons (Lovden et al., 2005). This study by Lovden et 
al indicates a dual task effect on the way-finding ability during motor activity in healthy 
people. We suggest that this approach may be useful to detect spatial navigation impairments 
also in patients with cognitive impairment and dementia.   
 
The Floor Maze Test (FMT) (Sanders et al., 2008), utilizes this approach by combining a 2-
dimensional maze task with walking and was presented as a clinical test of spatial navigation 
with real-life applicability. The combined walking and navigation in the FMT may provide an 
opportunity to identify navigational impairments at a very early stage of cognitive impairment. 
It should be kept in mind that spatial navigation is one of several interrelated cognitive 
domains, and successful navigation requires contributions from other cognitive processes such 
as visual perception, learning, memory, and executive functions (Moffat, 2009). In a sample 
of cognitively healthy elderly subjects, the FMT was associated primarily with executive 
function, as well as memory function (Sanders et al., 2008). Findings from previous studies, 
using other measures of spatial abilities, have not been consistent regarding the contribution 
from standard cognitive test batteries, or demographical factors, on performance of navigation 
tasks (Benke et al., 2013;deIpolyi et al., 2007), which leaves a concern that navigational 
impairments may go undetected. 
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The FMT is a relatively new test so we believe it is important to develop an understanding of 
which other cognitive domains contribute to the performance on the FMT. The aims of this 
study were to explore 1) whether there are any differences with regard to performance on the 
FMT between patients with SCI and MCI and between patients with MCI and mild AD; and 2) 
which sociodemographic factors and tests in the routine cognitive test battery used in memory 
clinics are related to the performance on the FMT. 
Methods 
Participants 
This cross-sectional study recruited patients from a larger study focused on gait and balance 
in patients with cognitive impairment (Tangen et al., 2014). For that study, the following 
inclusion criteria were used: 1) ability to walk without a walking device; 2) be home-dwelling; 
3) be able to follow instructions in Norwegian; and 4) have a tentative diagnosis of SCI, MCI, 
or mild to moderate AD. The exclusion criteria were moderate to severe pain when walking, 
other dementia disorders, other severe neurological disease, or severe hearing and vision 
impairment. In this study, moderate AD was an additional exclusion criterion. The patients’ 
eligibility was determined based on clinical judgment of information from the patients, carers, 
staff at the memory clinic and medical records. Patients from the Memory Clinic at Oslo 
University Hospital were consecutively enrolled from January 2011 to August 2012.  
Furthermore we included seven patients with SCI during November 2013. All patients 
provided their informed written consent, and the study was approved by the Regional 
Committee for Medical and Health Research Ethics in the Southeast of Norway. 
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Demographic and clinical information 
All participants were included in the Norwegian Dementia Registry (NDR), and data from 
this registry and the patients’ medical records were used to obtain the demographic 
characteristics, medical information, and cognitive assessments. A very experienced geriatric 
psychiatrist (KE) blinded to the FMT results reviewed all of the tentative diagnoses after the 
patients’ first visit to the memory clinic. Patients with subjective memory complaints that did 
not meet the criteria for MCI were classified as having SCI. For the MCI diagnosis, we 
applied the Winblad criteria: self and/or informant-reported cognitive impairment and one or 
more results more than1.5 SD below the normative means in the cognitive test battery, but 
still having no or minimal functional impairment (Winblad et al., 2004). We used the 
International Classification of Diseases-10 diagnostic criteria for research to diagnose AD and 
to determine if the AD status was mild or moderate (patients with the latter were excluded) 
(World Health Organization, 1993). The assessment of gait speed (10-meter test) was 
conducted in a quiet corridor at the Memory Clinic, with the patients instructed to walk at 
their usual pace. Timing began when the patient began to walk and ended when they crossed 
the 10-meter line. 
Cognitive assessments 
The Mini Mental Status Examination (MMSE) was used to assess global cognition (Folstein 
et al., 1975), which can be scored from 0–30, with higher scores indicating better 
performance. The Trail Making Test (TMT)-A was used to evaluate attention and processing 
speed, and the TMT-B was used to examine executive function and set-shifting ability 
(switching between multiple tasks) (Reitan, 1955). Attempts on the TMTs were interrupted 
after 5 minutes, although patients were allowed to continue if they insisted (no performances 
exceeding 6 minutes are reported). The Clock Drawing Test (CDT) was utilized to evaluate 
8 
 
visuo-constructive abilities, applying a dichotomized score of correct versus incorrect based 
on the Shulman scoring system (5 versus ≤4) (Shulman, 2000). The learning aspect of 
memory was evaluated with the Word List Memory test from the Consortium to Establish a 
Registry for Alzheimer’s Disease (scored 0–30, where 30 is best) (Fillenbaum et al., 2008). 
Floor Maze Test procedure 
The FMT was created based on the illustration in the original paper (Sanders et al., 2008); we 
used a 7 × 10 foot solid dark blue wax cloth with white tape indicating the lines of the maze 
(Figure 1). The same physical therapist conducted all of the FMT assessments. The patients 
were positioned at the entry of the maze and then given instructions. Three components of the 
FMT were timed: 1) planning time (PT), the time from finishing the instructions until the 
patient started to walk; 2) immediate maze time (IMT), the time spent walking through the 
maze from entry to exit; and 3) delayed maze time (DMT), the time spent walking through the 
maze a second time ten minutes after the initial performance, with other walking tests 
conducted between the two maze walks. Corrections during the walk were counted, and if a 
patient asked for advice during the walk, the initial instructions were repeated. Two different 
outcomes were utilized on the FMT: timed performances for the PT, IMT, and DMT and a 
dichotomous score of error-free performance versus performance with errors or 
discontinuation of the IMT. Psychometric properties are yet not established for the FMT. 
Statistical analysis 
Data were analyzed using the IBM SPSS Statistics version 20 (IBM Corp., Armonk, NY, 
USA) with a 5% level of significance. Group differences on the demographic variables with a 
normal distribution were analyzed by a one-way analysis of variance, Kruskal-Wallis tests 
were used for variables with a skewed distribution, and chi-square statistics were used for 
categorical variables. Comparisons between the patients that were included and omitted from 
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the regression analyses were conducted by t-tests (age, education and gait speed), by Mann-
Whitney U-test (MMSE), and chi-square tests (sex and comorbidities). Data are presented as 
the mean and SD, the median and first and third quartiles (Q1 and Q3), or as a frequency. 
 
To analyze group differences on the FMT we applied chi-square statistics for the dichotomous 
variable of error-free vs with-error performances on the IMT and DMT, and we applied 
Mann-Whitney U-tests to analyze the differences in the timed FMT-components between the 
SCI and MCI groups and between the MCI and AD groups. Comparisons between the patient 
groups that were included and omitted from the regression analysis were conducted by t-tests 
(age, education, and gait speed), a Mann-Whitney U-test (MMSE), and chi-square tests (sex 
and comorbidities). 
 
The relationship between the FMT and the independent variables were analyzed using 
multiple regression models. Because the timed performances for the PT, IMT, and DMT had 
skewed distributions, these variables were log transformed prior to the regression analysis. 
Correlation analyses were performed to check for collinearity among the independent 
variables. A multiple linear regression analysis was performed by entering all of the 
independent variables into the model and performing a manual stepwise backward regression 
analysis, removing the least significant variables until only the significant variables were left. 
The regression coefficients and confidence intervals were back transformed by the formula 
[exp(estimate) - 1] X 100 %, and are reported as per cent (%).To detect a large effect size 
(>0.35) with 80% power and a significance level of 0.05 for nine independent variables in the 
regression analyzes, we estimated that 54 patients would be required, thus we had the 
necessary sample for these analysis. As this was an exploratory study we did not perform 
power analyzes for the group comparisons.   
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Results 
As presented in Table 1, 128 patients (69 men; 53.9%) were included: 19 with SCI, 20 with 
MCI, and 89 with mild AD. The mean (SD) age was 69.8 (8.1) years, and the median (Q1, Q3) 
MMSE was 26.0 (24, 28). There were no significant differences between the groups with 
regard to age, sex, or education (p > 0.18). Sixteen patients (15 with AD and 1 with SCI, 
mean (SD) age 71.3 (10.7) and MMSE 23.3 (4.1)) gave up to complete the IMT, and had thus 
no valid results for the IMT and the DMT, and we also excluded them from the analyses of 
the PT-component. Five patients did not complete the DMT due to time constraints. 
 
The Fisher’s exact test we ran to evaluate the difference in the percentage of error-free 
performance on the IMT between the SCI group and the MCI group (84.2% vs. 75 % error-
free performance) indicated no significant differences (p = 0.70). The percentage of error-free 
performance did significantly differ ( (1, N = 109) = 7.3, p = 0.007) between the groups of 
MCI and mild AD (75 % vs. 41.6 % error-free performance). 
 
The SCI group was significantly faster than the MCI group on all three FMT components: PT 
(p = 0.013), IMT (p = 0.021), and DMT (p = 0.031), and the effect sizes ranged from 0.35 
(DMT) to 0.40 (PT). The MCI group was significantly faster than the AD group on the DMT 
(p = 0.02), but not on the PT (p = 0.57) or IMT (p = 0.12). There were no significant 
differences regarding time used as a whole between the PT and IMT (p = 0.46) or between the 
IMT and DMT (p = 0.39). 
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In the regression analysis (Table 3) we had one or more missing pieces of data in 30 patients, 
primarily related to the TMT‒B. We did not impute missing data, as these were not missing at 
random. Thus, the regression analysis consisted of 82 (64%) of the 128 patients enrolled in 
the study: 15 with SCI, 19 with MCI, and 48 with mild AD. The sample in the regression 
analysis had significantly higher educational levels (p = 0.030), better MMSE scores 
(p < 0.001), and faster walking rates (p < 0.001) than those patients who were omitted. There 
were no significant differences in their age, sex, or medical conditions (p > 0.05). 
 
The PT was moderately correlated with the DMT (r = 0.30, p = 0.002), but not with the IMT 
(r = 0.15, p = 0.11), while the IMT and DMT were highly correlated (r = 0.65, p < 0.001). All 
independent variables had correlations below r = 0.7; therefore, none were omitted from the 
analyses. In the multiple linear regression analysis, the MMSE was the only variable that was 
significantly associated with the PT, adjusted R
2
 = 0.04; F1,80 =4.0, p =0.049) (Table 4). 
TMT‒B was the only variable significantly associated with the IMT (adjusted R2 = 0.23; F1,80 
=25.3, p <0.001), and it also contributed to the final DMT (adjusted R
2
 = 0.31; F2,74 = 18.3, p 
<0.001) model together with the Word List Memory test. The B-coefficient of 0.4 % indicates 
that if the performance on the TMT‒B increases with 10 seconds, the corresponding change 
on IMT is 4 %. The sociodemographic factors were not significantly associated with any of 
the three FMT components. The estimated effect size [f 
2
 = R
2
/(1 − R2)] of the multiple 
regression model was small for the PT (f 
2
 = 0.12), while the IMT (f 
2
 = 0.41) and DMT 
(f 
2
 = 0.56) effect sizes were large (Cohen 1992).  
Discussion 
In this study, patients with MCI were slower on all the three components of the FMT than the 
patients with SCI, while the patients with mild AD completed the IMT with errors or gave up 
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more often than the patients with MCI. Executive function, as measured by the TMT‒B, was 
significantly associated with both the IMT and DMT. None of the sociodemographic variables 
were significantly associated with the FMT components. 
 
We found few indications of spatial navigation impairments in the SCI group; since all but 
one of our SCI patients were able to complete the IMT without errors, and the SCI group was 
also faster than the MCI group on the FMT components. These results are in concordance 
with previous studies that have reported no deficits in spatial navigation in patients with SCI 
(Hort et al., 2007; Kalova et al., 2005).  We found more deficits of spatial navigation in the 
patients with mild AD than in those with MCI. This is in line with findings from previous 
studies (Benke et al., 2013; Cushman et al., 2008; deIpolyi et al., 2007), although studies 
focused on the subgroups of MCI have found no differences between amnestic MCI 
(primarily memory impairments) and AD patients regarding spatial navigation (Hort et al., 
2007; Laczo et al., 2012).  However, the patients in the MCI group were not faster than the 
patients in the AD group on the PT or IMT. So, the patients in the MCI group were generally 
able to solve the navigational task, but their performances were slow, which may reflect 
increased effort to carry out the tasks. This is in line with the idea that the continuum from 
healthy persons to MCI, and then to AD also involves functional limitations, including spatial 
skills (Johnson et al., 2009; Benke et al., 2013; Hort et al., 2007). Our results corroborate 
findings from previous studies that indicate navigational impairments occur before patients 
fulfill the diagnostic criteria for AD, but they may not be a central feature of SCI. 
 
In this study, we found a significant association between the FMT and the tests in a standard 
cognitive test battery. Executive function, measured by the TMT-B, was significantly 
associated with both the IMT and DMT. Memory, measured by the Word List Memory test, 
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was associated with the DMT, and global cognition (assessed by MMSE) was associated with 
PT. These findings largely agree with the original study (Sanders et al., 2008), where the 
executive function and attention factor were related to all three components of the FMT. Our 
findings also agree with a study where both executive function and memory were predictors 
of poor performance on a route-learning test in patients with MCI or AD (Benke et al., 2013). 
Other studies have identified executive function as important for “getting-lost behavior” 
(assessed by questionnaire) in home-dwelling patients with AD (Chiu et al., 2005). Problem 
solving and maintaining attention are related to way-finding and spatial abilities, but they are 
also central features of the executive function (Passini et al., 1995). 
 
Memory was significantly associated with the DMT, but not the IMT, which contrasts with 
Sanders’ study that found the opposite (Sanders et al., 2008). However, it is reasonable for 
memory impairments to be more related to the DMT than the IMT in our sample, which is 
characterized by impaired memory function. It is also interesting to note that our patients 
devoted the same amount of time to all of the components of the FMT. This stands in contrast 
to Sanders’ cognitively healthy sample, which spent less time on the IMT component than on 
PT, and less time on the DMT component than on the IMT, indicating a learning process 
occurred throughout the test. 
 
The PT and IMT were not correlated, and there was a clear difference in the explained 
variance between the PT (4%) and the IMT/DMT (23/31%) in our study. This point to two 
different factors. First, the PT and IMT/DMT measure two different aspects of spatial 
navigation. There is likely a substantial difference between planning a walk standing at a 
fixed point and actually executing the planned walk while rotating the map as turns in the 
maze are made. Second, although we found significant associations between the cognitive 
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tests and FMT, we should be careful not to overestimate their importance. The explained 
variance is relatively low, indicating our standard cognitive test battery does not sufficiently 
capture impairments in spatial navigation. 
 
None of the demographic factors were independently associated with any of the FMT 
components. Several studies have found an age-effect on navigation, where younger people 
perform better than those that are older. However, these studies typically compared 
individuals in their twenties to people 60–80-years old (Cushman et al., 2008; Taillade et al., 
2013). Our patients were all between 51 and 83-years old, which may explain why no age-
effect was seen in our study. Our results also agree with the results from Benke’s study, where 
none of the demographic factors (age, sex, and education) were predictors for route-learning 
performance in patients referred to a memory clinic (Benke et al., 2013). 
 
A shortcoming of this study is that the cross-sectional design prevents us from drawing 
conclusion related to decline of navigational abilities. Further, all patients were recruited from 
a memory clinic, and this limits the generalizability of our findings to the populations 
normally seen by specialist outpatient clinics. In addition, the SCI and the MCI groups were 
small, and the heterogeneity in these two conditions should lead to a cautious interpretation of 
the findings regarding group differences. However, recruiting patients from a memory clinic 
is also a strength of this study, because we have a sample consistently examined with the 
same diagnostic protocol. We also believe patients with SCI recruited from memory clinics 
may have a higher risk for future cognitive decline than individuals with SCI in population-
based studies. 
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We acknowledge that even though the FMT involves walking, it is obviously still far from a 
test of real-life spatial navigation, given the lack of use of landmarks, a limited-sized surface, 
and only being two-dimensional. However, the FMT consumes little time and is an 
inexpensive test that does not require advanced equipment, and our study has shown that it is 
feasible for patients with a mild degree of cognitive impairment. Nevertheless, future studies 
are needed to validate the FMT against real-life navigational tasks and to provide normative 
values to increase the interpretability of results. 
Conclusion 
The performance on the FMT worsened with the increasing severity of cognitive impairment. 
The FMT was associated primarily with executive function and memory; however, the 
explained variance was relatively low, suggesting the standard cognitive test battery does not 
capture impaired spatial navigation. Sustained participation in both social and physical 
activities is important for people with dementia, and therefore we believe it is important to 
identify those individuals who experience impaired spatial navigation. However, our findings 
need to be confirmed in future larger cohort studies. 
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Tables and figure legends 
 
Figure 1. The Floor Maze test. The start is indicated by the arrow.    
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Table 1.  Demographic characteristics of the patients (n = 128) 
 n All (n = 128) SCI (n = 19) MCI (n = 20) Mild AD (n = 89) p
 
Age, mean (SD) 128 69.8 (8.1) 69.2 (6.6) 67.3 (7.6) 70.6 (8.4) 0.24
a
 
Men, n (%) 128 69 (53.9%) 11 (57.9%) 7 (35.0%) 51 (57.3%) 0.18
b
 
Education, mean (SD) 126 13.9 (3.4) 14.8 (3.4) 13.6 (3.3) 13.7 (3.4) 0.38
a
 
Gait speed, m/s, mean (SD) 128 1.15 (0.22) 1.26 (0.18) 1.20 (0.15) 1.12 (0.24) 0.02
a
 
Cholinesterase inhibitors, n (%) 126 28 (22.2%)
 
0 (0%) 0 (0%) 28 (31.8%) <0.001
b 
       
Mini Mental Status Exam, median (Q1, Q3) 128 26.0 (24.0, 28.0) 29.0 (29.0, 30.0) 28.0 (26.3, 29.0) 25.0 (22.0, 27.0) <0.001
c
 
Word List Memory, mean (SD) 118 14.8 (5.3) 21.9 (3.0) 17.4 (3.9) 12.9 (4.4) <0.001
a
 
Clock drawing test, correct n (%) 127 65 (50.8%) 16 (84.2%) 16 (80.0%) 33 (37.1%) <0.001
b
 
Trail Making Test-A, median (Q1, Q3) 123 48 (36, 74) 38 (30, 53) 37.5 (30.5, 44.8) 56.5 (40.0, 90.0) <0.001
c
 
Trail Making Test-B, median (Q1, Q3) 93 119 (86, 180) 91 (74, 127) 106.5 (85.3, 132.8) 145.0 (104.3, 238.0)  0.002
c
 
       
Musculoskeletal disorders, n (%) 128 55 (43.0%) 8 (42.1%) 7 (35.0%) 40 (44.9%) 0.72
b
 
Cardiovascular disease, n (%) 128 56 (43.8%) 8 (42.1%) 5 (25.0%) 43 (48.3%) 0.16
b
 
Neurological disease, n (%) 128 16 (12.5%) 3 (15.8%) 2 (10.0%) 11 (12.4%) 0.86
b
 
a
One-way analysis of variance; 
b
Chi-square test; 
c
Kruskal-Wallis test.  
SD, standard deviation; (Q1, Q3), 1
st
 and 3
rd
 quartiles; SCI, subjective cognitive impairment; MCI, mild cognitive impairment; AD, Alzheimer 
disease. p = level of significance. 
 
Table 2.  Group comparisons of the Floor Maze Test performances 
22 
 
 SCI MCI Mild AD SCI vs MCI
b
 MCI vs mild AD
b
 
Completed FMT n = 18 n = 20 n = 74 U p r U p r 
Planning Time, seconds
a
  19.5 (12.8, 35.5) 33.5 (21.1, 58.3) 31 (16.0, 53.8) 95.5 0.013
b
 0.40 669.5 0.52
b
 0.07 
Immediate Maze Time, seconds
a
 17.0 (14.8, 20.0) 22.5 (18.5, 47.2) 34 (22.3, 73.3) 101.0 0.021
b
 0.38 570.5 0.12
b
 0.16 
Delayed Maze Time, seconds
a
 13.0 (10.5, 22.5) 21.4 (16.1, 30.8) 34.8 (20.8, 72.0) 99.5 0.031
b
 0.35 413.5 0.02
b
 0.26 
a
median (1
st
 quartile, 3
rd
 quartile); 
b
Mann-Whitney U-test 
SCI, subjective cognitive impairment; MCI, mild cognitive impairment; AD, Alzheimer disease; IMT, immediate maze time; FMT, floor maze 
test. p = level of significance, r = effect size. 
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Table 3. Simple linear regression analysis between the three Floor Maze Test components (log transformed) and the sociodemographic factors, 
gait speed, and cognitive assessments.  
 Planning time (n =82) Immediate Maze Time (n =82) Delayed Maze Time (n =77) 
B
a
 95% CI p B
a
 95% CI p B
a
 95% CI p 
Age 0.2 -1.9, 2.3 0.853 0.7 -1.2, 2.7 0.436 1.7 -0.4, 3.9 0.111 
Sex (male = 0, female =1) 31.9 -5.1, 83.3 0.097 12.9 -16.7, 53.1 0.430 10.4 -21.0, 54.2 0.558 
Education -3.2 -7.8, 1.4 0.168 -2.3 -6.5, 2.1 0.298 -3.3 -7.7, 1.3 0.156 
Gait speed (m/s) -30.8 -67.5, 47.1 0.334 -41.0 -70.2, 17.0 0.129 -50.3 -77.0, 7.0 0.074 
Mini Mental Status Examination -6.4 -12.3, -0.03 0.049 -5.8 -11.3, -0.1 0.048 -10.1 -15.4, -4.5 0.001 
Word List Memory -2.8 -5.9, 0.6 0.102 -3.3 -6.2, -0.4 0.025 -5.9 -8.8, -3.0 <0.001 
Clock Drawing Test (incorrect =0, correct =1) -15.0 -40.4, 21.1 0.362 -27.3 -47.1, -0.2 0.049 -44.9 -60.5, -23.3 0.001 
Trail Making Test A 0.4 -0.3, 1.2 0.257 1.0 0.3, 1.6 0.004 1.4 0.7, 2.2 <0.001 
Trail Making Test B 0.2 -0.01, 0.4 0.061 0.4 0.3, 0.6 <0.001 0.5 0.3, 0.7 <0.001 
a
Unstandardized coefficients are back transformed by the formula [exp(estimate) - 1] X 100 %, and reported as per cent (%). 
CI, confidence interval. p = level of significance 
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Table 4. Final multiple regression models of the associations between the three Floor Maze Test components (log transformed) and independent 
variables: cognitive tests, sociodemographic factors, and gait speed 
 Planning time (n = 82) 
Adjusted R
2
 = 0.04 
Immediate Maze Time (n = 82) 
Adjusted R
2
 = 0.23 
Delayed Maze Time (n = 77) 
Adjusted R
2
 = 0.31 
B
a
 95% CI p B
a
 95% CI p B
a
 95% CI p 
Mini Mental Status Examination -6.4 -12.3, -0.1 0.049       
Word List Memory       -3.6 -6.5, -0.6 0.018 
Trail Making Test B     0.4 0.3, 0.6 <0.001 0.4 0.2, 0.6 <0.001 
a 
Unstandardized coefficients are back transformed by the formula [exp(estimate) - 1] X 100 %, and reported as per cent (%). 
CI, confidence interval. Variables age, sex, education, gait speed, Clock Drawing Test, and Trail Making Test-A did not contribute to any of the 
final models. p =level of significance 
